01 4Ubrelvy
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 125
2019 Revenue in Millions : 0
Growth (%) : New Launch
Main Therapeutic Indication : Neurology
Currency : USD
2021 Revenue in Millions : 552
2020 Revenue in Millions : 125
Growth (%) : 342
Main Therapeutic Indication : Neurology
Currency : USD
2022 Revenue in Millions : 680
2021 Revenue in Millions : 552
Growth (%) : 23
Main Therapeutic Indication : Neurology
Currency : USD
2023 Revenue in Millions : 815
2022 Revenue in Millions : 680
Growth (%) : 20
